Risperidone

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Olodaterol. Indication COPD 

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Ondansetron base. Indication: Emesis

EU-US DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Ondansetron hydrochloride. Indication: Emesis

CEP and US DMF

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Prasugrel base. Indication: Prophylaxis and therapy of thrombosis

EU DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Quetiapine hemifumarate. Indication: Schizophrenia, psychosis

JP and KR DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Revefenacin for COPD treatment

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Rivaroxaban. Indication: Thrombosis. Stroke

DMF available

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Salmeterol xinafoate. Indication Asthma and COPD

CEP/ US-CN-KR DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Tetrabenazine. Indication: Hungtington's disease chorea and Tardive dyskinesia

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Tiotropium Bromide for COP

CEP and US-CN DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Umeclidinium for COPD 

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Vilanterol Trifenatate for Asthma and COPD 

Complete overview of Inke’s API product portfolio and development pipeline, covering Inhalation, CNS, Ophthalmic HPAPIs and Specialty APIs. The document includes product indications, micronisation availability, regulatory status (CEPs and DMFs), and development stage information for pipeline products.